Register for our free email digests:
Pricing Strategies; Reimbursement
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
UK Prices Show Volatility Of Recent Launches
Double-digit rises and falls in the average prices of recently-launched generics recorded by market researcher WaveData demonstrated the volatile pricing dynamics of the UK market in December.
Australian Experts To Weigh Paying For Trastuzumab Biosimilars
US Court Denies Attempt To Silence Leaks In Pricing Litigation
A host of leading generics firms have been denied a requested order to prevent leaks and potentially harmful public allegations as part of multi-district litigation over generics pricing in the US.
Coherus Confirms Udenyca Launch And Brings In Chief Medical Officer
The California-based biosimilars player has come good on its promise to introduce early in the new year its first biosimilar in the US and the second biosimilar of Amgen’s Neulasta blockbuster; at the same time, biotech veteran Darlene Horton has joined Coherus’ management team.
Leaks And Prejudice Must End In US Multi-State Pricing Case
A host of leading generics firms have banded together to call for an order to prevent leaks and potentially harmful public allegations, as they confront ongoing multi-district litigation over generics pricing in the US.
UK Price Concessions Fail To Keep Pace With Treble-Digit Rises
As several generic presentations see treble-digit average price rises in the UK, the country’s health department has reacted with a raft of price concessions. However, these have not always matched the prices recorded by market researcher WaveData.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.